Multiple Endpoints in Clinical Trials: Hierarchy, Co-Primaries, and Error Control
A rigorous analysis of multiplicity management in clinical trials, comparing FDA's 2022 final guidance and EMA's 2002 Points to consider across co-primaries, hierarchies, and gatekeeping.
9 minBy
